| Product Code: ETC6916869 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The Czech Republic`s import trend for gamma-aminobutyric acid (GABA) receptor agonists saw significant growth from 2023 to 2024, with a growth rate of 33.22%. The compound annual growth rate (CAGR) for the period 2020-2024 stood at an impressive 131.92%. This surge in imports can be attributed to increasing demand for GABA receptor agonists in the Czech Republic market, reflecting a shift in consumer preferences towards such products.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Czech Republic Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Overview |
3.1 Czech Republic Country Macro Economic Indicators |
3.2 Czech Republic Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, 2021 & 2031F |
3.3 Czech Republic Gamma-aminobutyric Acid (GABA) Receptor Agonist Market - Industry Life Cycle |
3.4 Czech Republic Gamma-aminobutyric Acid (GABA) Receptor Agonist Market - Porter's Five Forces |
3.5 Czech Republic Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Czech Republic Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.7 Czech Republic Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume Share, By Therapeutics, 2021 & 2031F |
3.8 Czech Republic Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Czech Republic Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume Share, By End Users, 2021 & 2031F |
3.10 Czech Republic Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Czech Republic Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the benefits of gamma-aminobutyric acid (GABA) receptor agonists in treating neurological disorders |
4.2.2 Growing prevalence of anxiety disorders and insomnia, leading to higher demand for GABA receptor agonists |
4.2.3 Rising investments in research and development for innovative GABA receptor agonist formulations |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approvals in the Czech Republic |
4.3.2 Limited availability of skilled healthcare professionals for prescribing GABA receptor agonists |
4.3.3 Potential side effects associated with long-term use of GABA receptor agonists |
5 Czech Republic Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Trends |
6 Czech Republic Gamma-aminobutyric Acid (GABA) Receptor Agonist Market, By Types |
6.1 Czech Republic Gamma-aminobutyric Acid (GABA) Receptor Agonist Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Czech Republic Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 Czech Republic Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Insomnia, 2021- 2031F |
6.1.4 Czech Republic Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Epilepsy, 2021- 2031F |
6.1.5 Czech Republic Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Spasticity, 2021- 2031F |
6.1.6 Czech Republic Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Anxiety, 2021- 2031F |
6.1.7 Czech Republic Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Czech Republic Gamma-aminobutyric Acid (GABA) Receptor Agonist Market, By Drugs |
6.2.1 Overview and Analysis |
6.2.2 Czech Republic Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Zolpidem, 2021- 2031F |
6.2.3 Czech Republic Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Topiramate, 2021- 2031F |
6.2.4 Czech Republic Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Baclofen, 2021- 2031F |
6.2.5 Czech Republic Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Czech Republic Gamma-aminobutyric Acid (GABA) Receptor Agonist Market, By Therapeutics |
6.3.1 Overview and Analysis |
6.3.2 Czech Republic Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Bamaluzole, 2021- 2031F |
6.3.3 Czech Republic Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Phenibut, 2021- 2031F |
6.3.4 Czech Republic Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Baclofen, 2021- 2031F |
6.3.5 Czech Republic Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Gaboxadol, 2021- 2031F |
6.4 Czech Republic Gamma-aminobutyric Acid (GABA) Receptor Agonist Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Czech Republic Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 Czech Republic Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.4.4 Czech Republic Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Intrathecal, 2021- 2031F |
6.4.5 Czech Republic Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Czech Republic Gamma-aminobutyric Acid (GABA) Receptor Agonist Market, By End Users |
6.5.1 Overview and Analysis |
6.5.2 Czech Republic Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Czech Republic Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.4 Czech Republic Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Czech Republic Gamma-aminobutyric Acid (GABA) Receptor Agonist Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Czech Republic Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 Czech Republic Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 Czech Republic Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Others, 2021- 2031F |
7 Czech Republic Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Import-Export Trade Statistics |
7.1 Czech Republic Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Export to Major Countries |
7.2 Czech Republic Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Imports from Major Countries |
8 Czech Republic Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Key Performance Indicators |
8.1 Patient adherence rate to GABA receptor agonist therapy |
8.2 Number of new product launches or formulations in the market |
8.3 Rate of adoption of GABA receptor agonists in clinical practice |
9 Czech Republic Gamma-aminobutyric Acid (GABA) Receptor Agonist Market - Opportunity Assessment |
9.1 Czech Republic Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Czech Republic Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Opportunity Assessment, By Drugs, 2021 & 2031F |
9.3 Czech Republic Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Opportunity Assessment, By Therapeutics, 2021 & 2031F |
9.4 Czech Republic Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Czech Republic Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Opportunity Assessment, By End Users, 2021 & 2031F |
9.6 Czech Republic Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Czech Republic Gamma-aminobutyric Acid (GABA) Receptor Agonist Market - Competitive Landscape |
10.1 Czech Republic Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenue Share, By Companies, 2024 |
10.2 Czech Republic Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |